R. Varin, P. Mulder, V. Richard, F. Tamion, C. Devaux et al., Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress, Circulation, vol.99, pp.2951-2957, 1999.

R. Varin, P. Mulder, F. Tamion, V. Richard, J. P. Henry et al., Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin, Circulation, vol.102, pp.351-356, 2000.

M. Vercauteren, R. E. Devaux, C. Dautreaux, B. Henry, J. P. Bauer et al., Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure, Circulation, vol.114, pp.2498-2507, 2006.

D. Elsner, A. Müntze, E. P. Kromer, and G. A. Riegger, Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure, Cardiovasc Res, vol.25, pp.438-440, 1991.

S. H. Kubo, T. S. Rector, A. J. Bank, R. E. Williams, and S. M. Heifetz, Endotheliumdependent vasodilation is attenuated in patients with heart failure, Circulation, vol.84, pp.1589-1596, 1991.

S. D. Katz, H. Krum, T. Khan, and M. Knecht, Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide, J Am Coll Cardiol, vol.28, pp.585-590, 1996.

M. Mohri, K. Egashira, T. Tagawa, T. Kuga, H. Tagawa et al., Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure, Hypertension, vol.30, issue.1, pp.50-56, 1997.

S. D. Katz, K. Hryniewicz, I. Hriljac, K. Balidemaj, C. Dimayuga et al., Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure, Circulation, vol.111, pp.310-314, 2005.

D. Fischer, S. Rossa, U. Landmesser, S. Spiekermann, N. Engberding et al., Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death, Eur Heart J, vol.26, pp.65-69, 2005.

J. N. Simon, D. Duglan, B. Casadei, and R. Carnicer, Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease, J Mol Cell Cardiol, vol.73, pp.80-91, 2014.

R. Joannides, C. Bizet-nafeh, A. Costentin, M. Iacob, G. Derumeaux et al., Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure, Hypertension, vol.38, pp.1446-1450, 2001.

M. Briet and E. L. Schiffrin, Vascular actions of aldosterone, J Vasc Res, vol.50, pp.89-99, 2013.

P. Mulder, S. Barbier, A. Chagraoui, V. Richard, J. P. Henry et al., Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, pp.1674-1679, 2004.

Y. Fang, M. Debunne, M. Vercauteren, E. Brakenhielm, V. Richard et al., Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia, J Cardiovasc Pharmacol, vol.59, pp.260-267, 2012.

M. Feldhammer, N. Uetani, D. Miranda-saavedra, and M. L. Tremblay, PTP1B: a simple enzyme for a complex world, Crit Rev Biochem Mol Biol, vol.48, pp.430-445, 2013.

E. Gomez, M. Vercauteren, B. Kurtz, A. Ouvrard-pascaud, P. Mulder et al., Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B, J Mol Cell Cardiol, vol.52, pp.1257-1264, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00801304

K. K. Bence, M. Delibegovic, B. Xue, C. Z. Gorgun, G. S. Hotamisligil et al., Neuronal PTP1B regulates body weight, adiposity and leptin action, Nat Med, vol.12, pp.917-924, 2006.

M. Shimoda, F. Mmanywa, S. K. Joshi, T. Li, K. Miyake et al., Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance, J Immunol, vol.176, pp.6503-6511, 2006.

C. E. Toutain, C. Filipe, A. Billon, C. Fontaine, L. Brouchet et al., Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization, Arterioscler Thromb Vasc Biol, vol.29, pp.1543-1550, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00410359

M. I. Ali, P. Ketsawatsomkron, E. J. Belin-de-chantemele, J. D. Mintz, K. Muta et al., Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone, Circ Res, vol.105, pp.1013-1022, 2009.

D. J. Herren, D. J. Herre, J. B. Norman, R. Anderson, M. L. Tremblay et al., Deletion of protein tyrosine phosphatase 1B (PTP1B) enhances endothelial cyclooxygenase 2 expression and protects mice from type 1 diabetes-induced endothelial dysfunction, PLoS One, vol.10, p.126866, 2015.

A. Agouni, S. Tual-chalot, M. Chalopin, L. Duluc, N. Mody et al., Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction, Biochem Pharmacol, vol.92, pp.607-617, 2014.

S. Gschwend, R. H. Henning, Y. M. Pinto, D. De-zeeuw, W. H. Van-gilst et al., Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade, Br J Pharmacol, vol.139, pp.1317-1325, 2003.

J. Hoefer, M. A. Azam, J. T. Kroetsch, H. Leong-poi, M. A. Momen et al., Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction, Circ Res, vol.107, pp.923-933, 2010.

M. Besnier, A. Galaup, L. Nicol, J. P. Henry, D. Coquerel et al., Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice, FASEB J, vol.28, pp.3351-3361, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02142777

A. A. Lanahan, D. Lech, A. Dubrac, J. Zhang, Z. W. Zhuang et al., PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells, Circulation, vol.130, pp.902-909, 2014.

S. P. Jones, J. J. Greer, R. Van-haperen, D. J. Duncker, R. De-crom et al., Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice, Proc Natl Acad Sci U S A, vol.100, pp.4891-4896, 2003.

P. B. Massion, C. Dessy, F. Desjardins, M. Pelat, X. Havaux et al., Cardiomyocyterestricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction, Circulation, vol.110, pp.2666-2672, 2004.

R. Gogiraju, X. Xu, M. L. Bochenek, J. H. Steinbrecher, S. E. Lehnart et al., Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice, J Am Heart Assoc, vol.4, 2015.